 "Stock picks by Prabhudas Lilladher: Buy Take Solutions, Sun Pharma")
BUY TAKE SOLUTIONS | CMP: Rs 49.4 | Target: Rs 65-70 | Stop Loss: Rs 44
The stock has witnessed a decent correction and has indicated signs of bottoming out near 46 levels and we anticipate a reversal. The RSI indicator has consolidated and is well placed for a trend reversal with the bias improving. With the chart looking good, we suggest to buy and accumulate this stock for an upside target of 65-70 levels, keeping the stop loss of 44.
BUY SUN PHARMACEUTICAL INDUSTRIES | CMP: Rs 524 | Target: Rs 600 | Stop Loss: Rs 485
Overall, the stock is in a rising trend and, currently, has taken support near 500 levels to indicate a reversal and improve the bias. The RSI indicator is also well placed and has indicated a trend reversal recently. With the chart looking good, we suggest to buy and accumulate this stock for an upside target of 600 levels, keeping the stop loss of 485.
Disclaimer: The author is an analyst with Prabhudas Lilladher. She may have positions in one or more stocks mentioned above. Views are personal.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%